Biotech ETFs Stage Solid Comeback at the Start of 2024 The biotech space staged a strong comeback at the start of 2024, driven by multi-billion dollar deals, upbeat clinical results and cutting-edge medical advances like CRISPR gene-editing hitting prime-time.
5 Least-Hurt Biotech ETFs of the Last Week Rising rate worries have weighed on the biotech sector. However, these biotech ETFs still have lost the least in recent days.
2 Sector ETFs Hovering Around a 52-Week High We all know that Wall Street is shattered this year. Still, two sectors -- Biotech and Aerospace -- have recently hit a 52-week high.
Biotech & Crypto -- Best ETF Areas of Last Week Biotech and cryptocurrency -- two ETF areas outperformed last week.
Biotech ETFs Rally as Global Blood Therapeutics Surges on Potential Pfizer Deal Biotechnology sector-related exchange traded funds continued to rally Friday on reports that Pfizer Inc. (NYSE: PFE) is looking to acquire Global Blood Therapeutics (NasdaqGS: GBT). On Friday, the Virtus LifeSci Biotech Products ETF (BBP) rose 1.8%, the SPDR S&P Biotech ETF (XBI) increased 3.6%, and the ALPS Medical Breakthroughs ETF (SBIO) was up 3.9%.
Biotech ETFs Advance on Speculation of a Takeover Bid for Global Blood Therapeutics Global Blood Therapeutics (NasdaqGS: GBT) shares climbed Thursday, lifting biotechnology sector-related exchange traded funds, on speculation of takeover bids for the small drug developer. On Thursday, the Virtus LifeSci Biotech Products ETF (BBP) rose 7.2%, the SPDR S&P Biotech ETF (XBI) increased 5.2%, and the ALPS Medical Breakthroughs ETF (SBIO) was up 5.1%.
Biotech ETFs Are Making a Comeback Biotechnology stocks and sector-related exchange traded funds have been gaining momentum as investors return to this downtrodden segment of the market. Over the past month, the Virtus LifeSci Biotech Clinical Trials ETF (BBC) gained 15.5%, the Virtus LifeSci Biotech Products ETF (BBP) rose 12.8%, the SPDR S&P Biotech ETF (XBI) increased 11.3% and the ALPS [.
Healthcare Emerges as Best Sector of Last Week: 5 Top ETFs Wall Street was downbeat last week with all indexes in the red. Still, Healthcare sector emerged as a key winner last week.